Search - tctmd.com

Displaying 61 - 80 of 108

Sort: Relevancy | Date

News Daily News

Shock in Peripartum Cardiomyopathy Especially Risky in Black, Hispanic Patients

Caitlin E. Cox

July 13, 2022

News Opinion CV Team Dispatch

July 2022 News Roundup

L.A. McKeown

July 01, 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Shelley Wood

May 25, 2022

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

L.A. McKeown

May 05, 2022

News Daily News

Underuse of GDMT for Heart Failure Even Worse in Low-Income Countries

Todd Neale

April 20, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults

L.A. McKeown

February 15, 2022

News Opinion Off Script

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

Charles C. Hong, MD, PhD

February 04, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Conference News AHA 2021

Empagliflozin Retains Benefits in ‘True’ HFpEF Patients

Todd Neale

November 17, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Daily News

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Todd Neale

July 06, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Fracking, Other Natural Gas Activity Linked to Hospitalizations for HF Patients

L.A. McKeown

December 07, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

News Conference News AHA 2020

One in Five Patients Admitted With COVID-19 Die in the Hospital

Michael O'Riordan

November 20, 2020

Advertisement

Shock in Peripartum Cardiomyopathy Especially Risky in Black, Hispanic Patients

July 2022 News Roundup

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

Underuse of GDMT for Heart Failure Even Worse in Low-Income Countries

March 2022 News Roundup

Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Empagliflozin Retains Benefits in ‘True’ HFpEF Patients

November 2021 News Roundup

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

FDA Approves Dapagliflozin for CKD Patients

Pneumonia in HF Patients Is Common, Lethal, and Preventable

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Fracking, Other Natural Gas Activity Linked to Hospitalizations for HF Patients

TCTMD’s Top 10 Most Popular Stories for November 2020

One in Five Patients Admitted With COVID-19 Die in the Hospital

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content